BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1981136)

  • 21. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulphasalazine in arthritis--an old drug rediscovered.
    Taggart AJ
    Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
    Verschueren P; Esselens G; Westhovens R
    Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in the research on antirheumatic drug: sulfasalazine].
    Li ZG; Shi GY
    Zhonghua Nei Ke Za Zhi; 1990 Apr; 29(4):243-5. PubMed ID: 1977564
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of clinical trials with fenbufen.
    Mawdsley P
    Arzneimittelforschung; 1980; 30(4A):740-6. PubMed ID: 7002163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-modifying agents and experimental treatments of rheumatoid arthritis.
    Weinblatt ME; Maier AL
    Clin Orthop Relat Res; 1991 Apr; (265):103-15. PubMed ID: 2009648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment in rheumatology with a new injectable salt of indomethacin].
    Coari G; Taccari E
    Minerva Med; 1974 Mar; 65(17):917-22. PubMed ID: 4545238
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects and side effects of 3-chlor-4-allyloxy-phenylacetic acid (Mervan) in therapeutic study of rheumatic diseases].
    Klemm C; Fricke R; Schattenkirchner M; Treiber W; Mathies H
    Z Rheumaforsch; 1971; 30(1):17-25. PubMed ID: 5315910
    [No Abstract]   [Full Text] [Related]  

  • 32. Variations between rheumatologists in using sulphasalazine.
    Scott DL; MacCarthy J
    Eur J Rheumatol Inflamm; 1991; 11(2):46-52. PubMed ID: 1365473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis.
    Williams HJ
    J Rheumatol Suppl; 1988 Sep; 16():9-13. PubMed ID: 2903928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect on symptoms treated with traditional Chinese medicine and western combination therapy in RA patients.
    He Y; Lu A; Zha Y; Tsang I
    Complement Ther Med; 2008 Aug; 16(4):206-11. PubMed ID: 18638711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphasalazine: mechanism of action in rheumatoid arthritis.
    Smedegård G; Björk J
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():7-15. PubMed ID: 8535652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical research with a new non-steroid drug, ibuprofen, in rheumatology].
    Marmont A; Rossi F; Bordo D
    Minerva Med; 1973; 64(48):2576-84. PubMed ID: 4580159
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ankylosing spondylitis--the current situation and new therapeutic options].
    Zlnay D; Zlnay M; Rovenský J
    Vnitr Lek; 2006; 52(7-8):730-5. PubMed ID: 16967616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.
    van der Horst-Bruinsma IE; Clegg DO; Dijkmans BA
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S67-70. PubMed ID: 12463451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulphasalazine in ankylosing spondylitis.
    Feltelius N; Hällgren R
    Ann Rheum Dis; 1986 May; 45(5):396-9. PubMed ID: 2872857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated cyclosporine therapy of peripheral arthritis associated with ankylosing spondylitis.
    Géher P; Gömör B
    Med Sci Monit; 2001; 7(1):105-7. PubMed ID: 11208503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.